Literature DB >> 8548782

Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy.

G Kogan1, J R Brisson, D L Kasper, C von Hunolstein, G Orefici, H J Jennings.   

Abstract

The type VII capsular polysaccharide isolated from the newly discovered group B Streptococcus (GBS) strain contains D-glucose, D-galactose, N-acetyl-D-glucosamine and N-acetylneuraminic acid in the molar ratio 2:2:1:1. High-resolution one- and two-dimensional (1D and 2D) 1H and 13C NMR spectroscopy of the native and desialylated polysaccharides showed the type VII GBS capsular polysaccharide to contain the following branched hexasaccharide repeating unit: [formula: see text] Despite extensive structural similarity with the previously described GBS polysaccharides, the type VII polysaccharide showed no cross-reaction with the heterologous antisera.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548782     DOI: 10.1016/0008-6215(95)00195-y

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  10 in total

1.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

Review 2.  Recent advances in understanding the molecular basis of group B Streptococcus virulence.

Authors:  Heather C Maisey; Kelly S Doran; Victor Nizet
Journal:  Expert Rev Mol Med       Date:  2008-09-22       Impact factor: 5.600

3.  Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII.

Authors:  Francesco Berti; Edmondo Campisi; Chiara Toniolo; Laura Morelli; Stefano Crotti; Roberto Rosini; Maria Rosaria Romano; Vittoria Pinto; Barbara Brogioni; Giulia Torricelli; Robert Janulczyk; Guido Grandi; Immaculada Margarit
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

4.  Structural and genetic diversity of group B streptococcus capsular polysaccharides.

Authors:  Michael J Cieslewicz; Donald Chaffin; Gustavo Glusman; Dennis Kasper; Anup Madan; Stephani Rodrigues; Jessica Fahey; Michael R Wessels; Craig E Rubens
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Genotyping of the capsule gene cluster (cps) in nontypeable group B streptococci reveals two major cps allelic variants of serotypes III and VII.

Authors:  M Sellin; C Olofsson; S Håkansson; M Norgren
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon.

Authors:  D O Chaffin; S B Beres; H H Yim; C E Rubens
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

7.  Molecular characterization of type-specific capsular polysaccharide biosynthesis genes of Streptococcus agalactiae type Ia.

Authors:  S Yamamoto; K Miyake; Y Koike; M Watanabe; Y Machida; M Ohta; S Iijima
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

8.  Discovery and characterization of sialic acid O-acetylation in group B Streptococcus.

Authors:  Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

9.  Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching.

Authors:  Hilde-Kari Guttormsen; Lawrence C Paoletti; Keith G Mansfield; Wojcieck Jachymek; Harold J Jennings; Dennis L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

10.  L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway.

Authors:  Youko Aoyagi; Elisabeth E Adderson; Craig E Rubens; John F Bohnsack; Jin G Min; Misao Matsushita; Teizo Fujita; Yoshiyuki Okuwaki; Shinji Takahashi
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.